Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT05863871
Real World Study of Linperlisib for Lymphoma Treatment
Sponsor: Ruijin Hospital
View on ClinicalTrials.gov
Summary
This is a multicenter, non-interventional and observational real-world study to evaluate the efficacy and safety of linperlisib in patients with lymphoma.
Official title: Real World Study of Linperlisib for Lymphoma Treatment: Multicenter, Non-interventional and Observational Real-world Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2023-05
Completion Date
2027-06
Last Updated
2023-05-18
Healthy Volunteers
No
Interventions
DRUG
Linperlisib
80 mg, qd
Locations (2)
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China
Tianjin Cancer Hospital/ Tianjin medical university cancer institute & hospital
Tianjin, China